Bioprinting– tag –
-
Global Pluripotent Stem Cell Therapies Progress to 115 Clinical Trials with Over 1,200 Patients, Demonstrating Strong Safety Profile
Vertex AI Search Global Overview Global clinical trials involving pluripotent stem cell therapies have significantly advanced, with 115 trials treating over 1,200 patients by December 2024, reporting no major safety concerns. This progre... -
Auxilium Biotechnologies Achieves Historic First: Bioprinting Kidney and Liver Tissues on ISS, Paving Way for Regenerative Medicine and Drug Discovery Breakthroughs
Business Wire / Auxilium Biotechnologies USA Overview Auxilium Biotechnologies successfully bioprinted kidney and liver tissues on the International Space Station (ISS) using its AMP-1 orbital 3D bioprinter, marking a world-first for the... -
Auxilium Biotechnologies Achieves World-First Space Bioprinting of Functional Kidney and Liver Tissues on ISS
Business Wire USA Overview Auxilium Biotechnologies successfully bioprinted kidney and liver tissues aboard the International Space Station using its AMP-1 orbital bioprinter, marking the first time these complex tissue types have been p... -
Auxilium Biotechnologies Pioneers Space Bioprinting on ISS, Successfully Producing Kidney, Liver Tissues, and Neural Implants
Business Wire USA Overview Auxilium Biotechnologies has successfully bioprinted kidney tissue, liver tissue, and 28 neural repair implants on the International Space Station (ISS). This marks the first time three distinct tissue types ha... -
Auxilium Biotechnologies Achieves Historic First with 3D Bioprinting of Kidney and Liver Tissue on International Space Station
Las Vegas Sun USA Overview Auxilium Biotechnologies has achieved a groundbreaking feat in space-based 3D bioprinting, successfully printing kidney and liver tissue for the first time aboard the International Space Station (ISS). This acc... -
VCU-Led Team Develops Novel Cancer Drug Discovery Platform Leveraging 3D Bioprinting and AI for Rapid Therapy Identification
VCU Massey Comprehensive Cancer Center USA Overview A scientific team from VCU Massey Comprehensive Cancer Center, UCLA Health Jonsson Comprehensive Cancer Center, and the University of Colorado School of Medicine has developed a new pla... -
3D Bioprinting Market Projected to Reach $6.21 Billion by 2030 Driven by Personalized Medicine and Organ Demand
The Business Research Company (via OpenPR) Unknown Overview This article provides an overview of a market research report published by The Business Research Company. The 3D bioprinting market is projected to expand to $6.21 billion by 20... -
3D Bioprinted Organoids Pave the Way for Clinical Translation in Oncology, Regenerative Medicine, and Drug Discovery
Reproductive Biology (Oxford Academic) UK Overview 3D bioprinted organoids are demonstrating significant advances in oncology, regenerative medicine, and drug discovery by more faithfully replicating in vivo tissue structures and functio... -
Vast Significantly Expands Microgravity Research and Manufacturing Network on Haven-1, Advancing Stem Cell Science, Regenerative Medicine, and Bioprinting
VAST USA Overview Vast has significantly expanded its microgravity research and manufacturing network by signing Memoranda of Understanding with key partners including UC San Diego's Sanford Stem Cell Institute, Auxilium Biotechnologies,... -
LambdaVision and Vast Sign MOU to Advance Space-Based Manufacturing of Protein-Based Artificial Retina on Commercial Space Stations
Business Wire USA Overview LambdaVision has signed a Memorandum of Understanding (MOU) with Vast to support research and manufacturing activities on Vast’s Haven-1 and future commercial space stations. LambdaVision has demonstrated, thro...
